Myron Jacobs
Pulmonary Disease · Saint Louis, MONPI 1255322731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 505 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,278 and has fallen 95.2% since, to $110 in 2025.
Across 505 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Boehringer Ingelheim$1K
- Actelion Pharmaceuticals US, Inc.$945
- AstraZeneca$943
- Bayer$483
- Novartis$377
- plus $3K from 33 others
What the payments were for
- Food & beverage$8,28898%
- Education$1872%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 126 | $1,316 |
| Boehringer Ingelheim | 61 | $1,090 |
| Actelion Pharmaceuticals US, Inc. | 42 | $945 |
| AstraZeneca | 61 | $943 |
| Bayer | 28 | $483 |
| Novartis | 19 | $377 |
| Grifols USA, LLC | 22 | $366 |
| United Therapeutics Corporation | 17 | $336 |
| Regeneron Healthcare Solutions, Inc. | 11 | $288 |
| Genentech USA, Inc. | 12 | $270 |
| Amgen | 11 | $204 |
| Electromed, Inc. | 18 | $182 |
| Insmed, Inc. | 6 | $178 |
| Mylan Specialty L.p. | 8 | $146 |
| Jazz Pharmaceuticals Inc. | 7 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $132 |
| Mallinckrodt Hospital Products Inc. | 5 | $130 |
| Itamar Medical Inc | 1 | $107 |
| Sanofi | 5 | $95 |
| Merck | 5 | $86 |
| Sunovion Pharmaceuticals Inc. | 6 | $84 |
| Baxter Healthcare | 2 | $78 |
| Harmony Biosciences LLC | 2 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Boston Scientific | 2 | $50 |
| Gilead | 3 | $50 |
| Resmed Corp | 2 | $48 |
| AbbVie | 2 | $35 |
| Fisher & Paykel Healthcare Inc | 2 | $26 |
| Shionogi Inc | 1 | $25 |
| Cumberland Pharmaceuticals, Inc. | 2 | $25 |
| Sandoz | 1 | $23 |
| Noah Medical Corporation | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Advanced Respiratory, Inc | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Circassia Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPTRAVI$125
- OPSUMIT$125
- WatchPATONE$107
How this compares
$8,474 in reported general payments places this provider in the 75th percentile of 295 pulmonary disease providers in Missouri.
Other pulmonary disease in Saint Louis
- Derek ByersSaint Louis$835K
- Alexander ChenSaint Louis$679K
- Joseph OjileSaint Louis$538K
- Edward CharbekSaint Louis$372K
- Marin KollefSaint Louis$264K
- Praveen ChennaSaint Louis$255K
- Murali ChakinalaSaint Louis$172K
- Janet LeeSaint Louis$143K
- Ali SadoughiSaint Louis$87K
- Ramsey HachemSaint Louis$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.